#Hybryte - Twitter Hashtag

BioWorld

@BioWorld

4 months ago

.@Soligenix_Inc plummets on trial halt for #Hybryte in #lymphoma https://t.co/hMaDcZHQz5 #biopharma

0

2

0

377

Benzinga @Benzinga

over 1 year ago

Soligenix $SNGX #HyBryte™ Shows 75% Response Rate In Skin Cancer Trial, Backed By #FDA Funding 💥 @Soligenix_Inc is a late-stage #biopharma company focused on developing & commercializing products to treat rare diseases 👉 https://t.co/Pk0SPF9xQ0 #cancer #ad #CTCL

3

2

0

3K

Soligenix, Inc. @Soligenix_Inc

almost 2 years ago

HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference #CTCL #hybryte https://t.co/5l7c9XNcCC

0

3

1

0

Soligenix, Inc. @Soligenix_Inc

about 2 years ago

Q&A with Dr. Ellen Kim, the Lead Principal Investigator for Soligenix’s Phase 3 FLASH study in CTCL: Soligenix's Hybryte: Lighting the Way Towards Commercial Success with Promising Flash Study Results https://t.co/kqA9KLZt5T #Hybryte #DefendYourHealth #biotech #clinicaltrials

0

3

2

0

PRISM MarketView

@PrismMarketView

about 2 years ago

PRISM MarketView Highlights @Soligenix_Inc (Nasdaq: $SNGX)Promising HyBryte™ Replication Trial: Setting the Stage for Success https://t.co/6HOzDUjDNw #stockstowatch #stocksinnews #investors #daytrader #PrismMarketView #PrismMediaWire #PrismDigitalMedia #soligenix #HyBryte #Tcelllymphoma

0

1

32K

TraderTV Research

@ttvresearch

over 3 years ago

$SNGX - Soligenix announces positive clinical results for the use of HYBRYTE™ in treating cutaneous T-cell lymphoma. #SNGX #cutaneousTcelllymphoma #HYBRYTE

0

5

1

0

803

Soligenix, Inc. @Soligenix_Inc

over 3 years ago

Check out our youtube channel for a video on today's news: #HyBryte #NDA application submission #defendyourhealth #ctcl https://t.co/bay0V7nwwk

0

2

1

0

Soligenix, Inc. @Soligenix_Inc

over 4 years ago

What about HyBryte™’s applicability beyond the clinic? We have plans to develop HyBryte for home use within 12-18 months of receiving FDA approval, and we’re looking at expanding HyBryte’s use for other indications in 2025. $SNGX #CTCL #HyBryte

Soligenix_Inc's tweet photo. What about HyBryte™’s applicability beyond the clinic? We have plans to develop HyBryte for home use within 12-18 months of receiving FDA approval, and we’re looking at expanding HyBryte’s use for other indications in 2025. $SNGX #CTCL #HyBryte https://t.co/7jKqSR2M05

0

2

1

0

Top Tweets for #Hybryte

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users